Delivery Order SPE2DB20D1100-SPE2DB25FD7B2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Adzenys XR-ODT 18.8 mg tablet units. The contract has a firm-fixed price of $1,580.82 and a completion date of September 27, 2024. It is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, under...
- The Defense Logistics Agency awarded a $236,240 delivery order to Amerisourcebergen Drug Corporation for the supply of 18.8 mg Adzenys XR-ODT tablets. The firm fixed price order calls for the delivery of 456,169,844 tablets to a facility in Conshohocken, Pennsylvania by August 4, 2023 to support the Department of Defense's pharmaceutical needs. Amerisourcebergen will serve as the prime contractor, with performance taking place at its corporate headquarters. No set aside provisions or...
- The Defense Logistics Agency awarded a $360,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 9.4 mg Adzenys XR-ODT tablets. The prime contractor will deliver 30 bottles of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of DLA programs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, procuring critical medical supplies and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,336.24 firm-fixed-price contract is for the supply of the prescription drug Adzenys XR-ODT 12.5 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of medical commodities to support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adzenys XR-ODT 9.4 mg tablets, with a ceiling value of $2,800.42 and an ultimate completion date of June 12, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,198.50, is for the delivery of ADZENYS XR-ODT 15.7 MG TABLET UD 30S, a pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a $1,642.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 3.1 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency Troop Support Medical awarded a $427,720 delivery order to Amerisourcebergen Drug Corporation for 12.5 mg tablets of ADZENYS XR-ODT to be delivered to their Conshohocken, Pennsylvania facility. The firm fixed price order is for 30 boxes of the extended release orally disintegrating tablets and will be fulfilled between July 3rd and July 5th, 2023 under the prime vendor's pharmaceutical supply contract vehicle. No subcontractors or set aside designations were...
- This is a $1,119.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 6.3 MG TABLET UD 30S, a prescription medication, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7B2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adzenys XR-ODT 3.1 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,063.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement awarded through competitive bidding. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion value through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Adzenys XR-ODT is an extended-release amphetamine-based medication indicated for attention-deficit/hyperactivity disorder (ADHD) treatment, reflecting the company's role as a critical vendor for military and federal healthcare system pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/29/25 |